L. Gordon Letts

NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA.

Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.

TargAnox, Inc. develops therapeutics to prevent oxidative stress diseases. Its products are used for the treatment of diseases and conditions that result from oxidative stress-induced modification of proteins. The company was founded by Joseph Loscalzo and L. Gordon Letts in 2008 and is headquartered in New York, NY.

Inflammation Research Association, Inc. engages in encouraging scientists, researchers, students, teachers and clinicians with an interest in inflammation biology. The company is headquartered in Newcastle, WA.

Merck Frosst Canada Ltd. is a Canadian pharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada. The company's mission is to save and improve lives by bringing forward solutions for some of the world's most challenging diseases.